PAMA & CLFS: what independent labs should watch next

CLFS rates and PAMA reporting continue to shape lab economics. Even labs that feel “far from Medicare” feel the ripple through commercial fee schedules.

Stay close to reporting windows, validate private-payer rate submissions, and model menu-level margin when rates move.

Your billing partner should flag CLFS-impacted CPTs in dashboards — not surprise you at year-end.